Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.8057 per EA under NDC 00054300001. Its NADAC has been published 213 times since Jun 1, 2022.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP
Butalbital, Acetaminophen, Caffeine and Codeine PhosphateStrength
325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054300001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA215138On Market Since
5/9/2022
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has been published 213 times since Jun 1, 2022, and over the history we have for it it has declined 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8057 per EA |
|---|---|
| All-time high | $0.9542 (Feb 15, 2023) |
| All-time low | $0.5885 (Nov 20, 2024) |
| 52-week high | $0.9086 |
| 52-week low | $0.8057 |
| Median price | $0.8784 |
| Average price | $0.8486 |
| Largest weekly change | +43.5% (Jul 20, 2022) |
| Weeks tracked | 213 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP, manufactured by Hikma Pharmaceuticals USA Inc., is $0.8057 per EA (NDC 00054300001), effective Jun 24, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has declined 6.2%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
Since Jun 1, 2022, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has ranged from a low of $0.5885 (Nov 20, 2024) to a high of $0.9542 (Feb 15, 2023), with a median of $0.8784 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP (NDC 00054300001) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification